Cancer Network spoke with Marleen Meyers, MD, about evidence on low-dose tamoxifen vs placebo in women who had surgery for their ductal carcinoma in situ.
Marleen Meyers, MD
Advertisement
Articles by Marleen Meyers, MD
Advertisement
Latest Updated Articles
Dr. Meyers on Low-Dose Tamoxifen vs Placebo After Surgery for DCIS Breast CancerPublished: June 17th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
3
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma
4
Palazestrant Combo Shows Preliminary Activity in ER+/HER2– Breast Cancer
5
